CRP and chronic obstructive pulmonary disease: One study showed that patients with COPD and an elevated C-reactive protein (CRP) at baseline showed a significant decrease in CRP levels following MSC treatment, suggesting that MSCs can inhibit the inflammation that is present in COPD [44].